Search results
'Dramatic' Phase 2 Results for Survodutide in MASH, Fibrosis
Medscape· 2 days agoSurvodutide, a dual agonist that targets glucagon and glucagon-like peptide 1 receptors, led to a...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0829 ET...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
Reuters via AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers...
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Medscape· 4 days agoEncouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...
REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
TipRanks via Yahoo Finance· 17 hours agoFor value investors looking to take a “break” from the euphoric technology stocks, many of which may...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
Reuters· 3 days agoThe U.S. Food and Drug Administration has granted accelerated approval French drugmakers Ipsen and...
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com
Investing.com· 3 days agoThe study, which involved healthy volunteers and patients with a history of liver cirrhosis, was...
US FDA grants accelerated approval to Genfit and Ipsen’s liver disease drug
WSAU Wausau· 3 days ago(Reuters) -The U.S. Food and Drug Administration has granted accelerated approval French drugmakers...
The 10 health benefits of giving up alcohol
The Telegraph via Yahoo News· 1 day agoIt’s often said that the British love their tea, discussing the weather and, let’s face it, enjoying a tipple. Little wonder, then, that research from...
Dr. Oz discusses how to stop overeating
NJ.com· 1 day agoOvereating happens because of an unchecked impulse to eat and a lack of being able to feel satiated. One reason may be that you aren’t getting the...
